Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10864-10872

  Phuphuakrat, Angsana ^a   Kraiwong, Romchat ^a   Boonarkart, Chompunuch ^a   Lauhakirti, Darat ^a   Lee, Tun Hou ^b   Auewarakul, Prasert ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DOUBLE STRANDED RNA; SMALL INTERFERING RNA; STRUCTURAL PROTEIN; VIRUS PROTEIN; VIRUS RNA; DSRNA ADENOSINE DEAMINASE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENVELOPE GENE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; RNA TRANSCRIPTION; UPREGULATION; VIRUS EXPRESSION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; CERCOPITHECUS; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADENOSINE DEAMINASE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE SILENCING; HIV-1; HUMANS; RNA, VIRAL; VIRAL PROTEINS;

EID: 55249089269     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00238-08     Document Type: Article

References (34)

1. Bourara, K., S. Litvak, and A. Araya. 2000. Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing. Science 289:1564-1566.
2. Bridge, A. J., S. Pebernard, A. Ducraux, A. L. Nicoulaz, and R. Iggo. 2003. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34:263-264.
3. Casey, J. L. 2006. RNA editing in hepatitis delta virus. Curr. Top. Microbiol. Immunol. 307:67-89.
4. Casey, J. L., and J. L. Gerin. 1995. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69:7593-7600.
5. Cattaneo, R., A. Schmid, D. Eschle, K. Baczko, V. ter Meulen, and M. A. Billeter. 1988. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55:255-265.
6. Cecilia, D., V. N. KewalRamani, J. O'Leary, B. Volsky, P. Nyambi, S. Burda, S. Xu, D. R. Littman, and S. Zolla-Pazner. 1998. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J. Virol. 72:6988-6996.
7. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
8. Eckmann, C. R., A. Neunteufl, L. Pfaffstetter, and M. F. Jantsch. 2001. The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Mol. Biol. Cell 12:1911-1924.
9. Galinski, M. S., R. M. Troy, and A. K. Banerjee. 1992. RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology 186:543-550.
10. Hamalainen, H. K., J. C. Tubman, S. Vikman, T. Kyrola, E. Ylikoski, J. A. Warrington, and R. Lahesmaa. 2001. Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal. Biochem. 299:63-70.
11. Harris, R. S., K. N. Bishop, A. M. Sheehy, H. M. Craig, S. K. Petersen-Mahrt, I. N. Watt, M. S. Neuberger, and M. H. Malim. 2003. DNA deamination mediates innate immunity to retroviral infection. Cell 113:803-809.
12. Herbert, A., and A. Rich. 2001. The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1. Proc. Natl. Acad. Sci. USA 98:12132-12137.
13. Holzinger, D., C. Jorns, S. Stertz, S. Boisson-Dupuis, R. Thimme, M. Weidmann, J. L. Casanova, O. Haller, and G. Kochs. 2007. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 81:7776-7785.
14. Jayan, G. C., and J. L. Casey. 2002. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76:12399-12404.
15. Kingsman, S. M., and A. J. Kingsman. 1996. The regulation of human immunodeficiency virus type-1 gene expression. Eur. J. Biochem. 240:491-507.
16. Lassen, K., Y. Han, Y. Zhou, J. Siliciano, and R. F. Siliciano. 2004. The multifactorial nature of HIV-1 latency. Trends Mol. Med. 10:525-531.
17. Liu, Y., C. X. George, J. B. Patterson, and C. E. Samuel. 1997. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272:4419-4428.
18. Mangeat, B., P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
19. Menzo, S., P. Bagnarelli, M. Giacca, A. Manzin, P. E. Varaldo, and M. Clementi. 1992. Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J. Clin. Microbiol. 30:1752-1757.
20. Ndung'u, T., B. Renjifo, and M. Essex. 2001. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone. J. Virol. 75:4964-4972.
21. Nishimori, H., T. Shiratsuchi, T. Urano, Y. Kimura, K. Kiyono, K. Tatsumi, S. Yoshida, M. Ono, M. Kuwano, Y. Nakamura, and T. Tokino. 1997. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15:2145-2150.
22. Paterson, R. G., and R. A. Lamb. 1990. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J. Virol. 64:4137-4145.
23. Persengiev, S. P., X. Zhu, and M. R. Green. 2004. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18.
24. Phuphuakrat, A., and P. Auewarakul. 2005. Functional variability of Rev response element in HIV-1 primary isolates. Virus Genes 30:23-29.
25. Polson, A. G., B. L. Bass, and J. L. Casey. 1996. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380:454-456.
26. Poulsen, H., J. Nilsson, C. K. Damgaard, J. Egebjerg, and J. Kjems. 2001. CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol. Cell. Biol. 21:7862-7871.
27. Saltarelli, M. J., E. Hadziyannis, C. E. Hart, J. V. Harrison, B. K. Felber, T. J. Spira, and G. N. Pavlakis. 1996. Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals. AIDS Res. Hum. Retrovir. 12:1443-1456.
28. Sanchez, A., S. G. Trappier, B. W. Mahy, C. J. Peters, and S. T. Nichol. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA 93:3602-3607.
29. Sato, S., S. K. Wong, and D. W. Lazinski. 2001. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 75:8547-8555.
30. Seshamma, T., O. Bagasra, D. Trono, D. Baltimore, and R. J. Pomerantz. 1992. Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:10663-10667.
31. Sharmeen, L., B. Bass, N. Sonenberg, H. Weintraub, and M. Groudine. 1991. Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc. Natl. Acad. Sci. USA 88:8096-8100.
32. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
33. Taylor, D. R., M. Puig, M. E. Darnell, K. Mihalik, and S. M. Feinstone. 2005. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79:6291-6298.
34. Yang, J. H., X. Luo, Y. Nie, Y. Su, Q. Zhao, K. Kabir, D. Zhang, and R. Rabinovici. 2003. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 109:15-23.